No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
HIMS Hims & Hers Health
- 12.330
- +0.450+3.79%
Close Apr 23 16:00 ET
- 12.350
- +0.020+0.16%
Pre 07:54 ET
2.64BMarket Cap-112090P/E (TTM)
12.560High11.910Low3.34MVolume12.000Open11.880Pre Close41.23MTurnover1.94%Turnover RatioLossP/E (Static)214.25MShares17.16052wk High7.68P/B2.13BFloat Cap5.65052wk Low--Dividend TTM172.45MShs Float25.400Historical High--Div YieldTTM5.47%Amplitude2.720Historical Low12.352Avg Price1Lot Size
Pre-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | NYSE Order Imbalance 132698.0 Shares on Sell Side
Zacks Investment Ideas Feature Highlights: Hims & Hers Health, Coinbase Global
Express News | NYSE Order Imbalance 117561.0 Shares on Sell Side 117561.0 Shares on Sell Side
Hims & Hers Health, Inc. (HIMS) Suffers a Larger Drop Than the General Market: Key Insights
Express News | NYSE Order Imbalance 91472.0 Shares on Sell Side 91472.0 Shares on Sell Side
Hims & Hers Health(HIMS.US) Officer Sells US$34,916.85 in Common Stock
$Hims & Hers Health(HIMS.US)$ Officer Boughton Soleil sold 2,503 shares of common stock on Apr 15, 2024 at an average price of $13.95 for a total value of $34,916.85.Source: Announcement What is state
Comments
$Hims & Hers Health(HIMS.US$ nice red to green action today
Hims & Hers Health's high P/S ratio is justified by strong future revenue growth. Investors are willing to pay a premium for the stock due to the company's growth potential and positive outlook.
4
ColumnsBiotechnology Stocks Climbing on Earnings and Test Results: What to Watch
$Viking Therapeutics (VKTX.US)$skyrocketed 77% after positive drug trial news Tuesday, leading to what proved to be a strong morning for pharmaceutical stocks.
Here are some top stocks in the sector climbing on drug trial and earnings news:
$Janux Therapeutics (JANX.US)$shares shot up 205% to $36.00 after the company announced updated clinical data for both of its clinical programs, reaching over $1.50B in market cap.
$Ligand Pharmaceuticals (LGND.US)$gained 23%...
Here are some top stocks in the sector climbing on drug trial and earnings news:
$Janux Therapeutics (JANX.US)$shares shot up 205% to $36.00 after the company announced updated clinical data for both of its clinical programs, reaching over $1.50B in market cap.
$Ligand Pharmaceuticals (LGND.US)$gained 23%...
6
Analysts praise Hims & Hers Health's solid Q4 performance and potential of personalized products to boost recurring revenues and customer loyalty.
ColumnsToday's Morning Movers and Top Ratings: ZM, LOW, M, CARG and More
Morning Movers
Gapping up
$Lowe's Companies(LOW.US$ Shares of Lowe's edged up by 0.3% as the home improvement retailer announced fourth-quarter net sales that exceeded analysts' expectations, despite a persistent slowdown in the home improvement spending sector.
$Zoom Video Communications(ZM.US$ shares jumped by 12% following the release of the video-conferencing company's fourth-quarter earnings, which surpassed projections, bu...
Gapping up
$Lowe's Companies(LOW.US$ Shares of Lowe's edged up by 0.3% as the home improvement retailer announced fourth-quarter net sales that exceeded analysts' expectations, despite a persistent slowdown in the home improvement spending sector.
$Zoom Video Communications(ZM.US$ shares jumped by 12% following the release of the video-conferencing company's fourth-quarter earnings, which surpassed projections, bu...
12
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg